SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Armada Acquisition Corp. I operates as a blank check company. It was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company was founded on November 5, 2020 and is headquartered in Philadelphia, PA.

Rezolve AI PLC .

Rezolve AI Limited

Rezolve AI ($RZLV) is trending amidst discussions about its valuation compared to AI peers and excitement around its upcoming earnings report on October 1st. The community is actively debating potential partnerships, market manipulation, and optimal entry points after a volatile trading session that saw a significant dip, with many viewing it as a buying opportunity before an anticipated surge. Long-term holders remain confident in the stock's potential, citing strategic partnerships and a belief that the company is significantly undervalued.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending amid a preliminary alliance with OpenAI, sparking community discussion around its potential impact and future prospects. Some investors believe this will be a catalyst, while others question the specifics of the agreement and its accretive value to MSFT. The news has contributed to a broader tech rally and boosted futures.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is trending as investors discuss the potential impact of AI on its earnings, with a mix of opinions on whether AI will drive growth or create competition. The community is focused on the company's AI-influenced ARR and forward guidance, with some anticipating a significant move post-earnings while others remain cautious due to past performance. There's also debate around Adobe's valuation and competitive positioning relative to other players in the creative software space.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

GALT is trending as the community discusses the potential for a short squeeze and buyout following positive signals regarding FDA's openness to new endpoints.  Optimism is fueled by strong insider ownership and upcoming presentations, with longs dismissing short positions and envisioning triple-digit gains.  Broader discussions include potential partnerships with larger pharmaceutical companies and speculation around a possible FDA approval, driving speculative interest.

RH operates as a holding company which operates the business through its subsidiary Restoration Hardware, Inc. It offers furniture, lighting, textiles, bath ware, decor, outdoor and garden, as well as baby and child products. The company operates an integrated business with multiple channels of distribution including galleries, source books and websites. The company was founded by Stephen J. Gordon in 1980 and is headquartered in Corte Madera, CA.

RH - Ordinary Shares - Class A

Restoration Hardware

RH is trending after earnings and forward guidance prompted mixed reactions, with some community members questioning the company's outlook while others see long-term potential. Discussions include the impact of tariffs and interest rates on the high-end consumer market, a key factor for Restoration Hardware's performance. Active trading strategies and potential short squeezes are also being discussed amidst the volatility.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery is trending amid speculation of a potential buyout offer from Paramount Skydance, generating excitement among investors. Community members are actively discussing potential deal terms, with some anticipating a bidding war, while others express skepticism about the valuation and financing. Many believe WBD's valuable content library makes it an attractive acquisition target, regardless of the final outcome.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

SMCI is trending following news of volume shipments of NVIDIA Blackwell Ultra systems, with community members discussing potential short squeezes and price targets. Some investors express concerns about management, while others highlight the company's partnerships and growth potential in the AI infrastructure space. Overall, the conversation is centered around the company's role in the AI sector and its potential for future growth.

Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. Its pipeline includes Dipraglurant, ADX71149, GABAB PAM, mGlu7 NAM, mGlu2 NAM, mGlu4 PAM, and mGlu3 PAM. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.

Addex Therapeutics Ltd - ADR

ADXN is trending due to significant after-hours volatility, with community members pointing to its small float, high cost to borrow, and potential for a short squeeze. Some traders speculate about a possible shift to a crypto treasury, while others caution about a potential pump and dump, given the lack of concrete news. Discussions also involve potential sympathy plays and comparisons to other high-flying stocks with similar characteristics.

SSgA Active Trust - SPDR Dow Jones Industrial Average ETF

DIA is trending due to discussions around potential market rotation toward Microsoft, fueled by news of its partnership with OpenAI. The community is actively assessing the impact of this shift and considering potential implications for other tech giants like Google. Broader market sentiment is also being influenced by recent economic data and speculation around future Federal Reserve actions.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

OPEN is trending due to excitement around a new CEO and board member additions, sparking a surge of bullish sentiment despite some volatility. The community is debating the potential for a short squeeze and the impact of future interest rate cuts on the housing market. Bears are being squeezed and a war is brewing.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vertex Pharmaceuticals (VRTX) Stock Slides as Market Rises: Facts to Know Before You Trade

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $388.55, marking a -2% move from the previous day.

Why Is Vertex (VRTX) Up 6.9% Since Last Earnings Report?

Vertex (VRTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Can CRSP's In Vivo Pipeline Aid Long-Term Growth Beyond Casgevy?

CRISPR Therapeutics pushes beyond Casgevy with in vivo programs like CTX310, CTX320 and plans for two more studies by 2025-end.

CRSP vs. BEAM: Which Gene Editing Stock Holds More Potential Right Now?

CRISPR Therapeutics gains momentum with Casgevy sales and a broader pipeline, while Beam Therapeutics advances base-editing therapies still in early stages.

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know  

Zacks.com users have recently been watching Vertex (VRTX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

CRISPR Therapeutics Gains 41.4% in 3 Months: How to Play the Stock

CRSP surges 41.4% in three months, fueled by promising CTX310 study data and accelerating Casgevy sales.

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

Vertex (VRTX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Can Rising Casgevy Sales Aid CRISPR Therapeutics Post Q2 Earnings?

CRSP's Casgevy records a 114% sales jump sequentially in Q2, fueling optimism for sustained revenues and long-term growth.

CRSP Stock Down on Huge Q2 Loss, Focus on Increasing Casgevy Adoption

CRISPR Therapeutics posts a wider second-quarter loss tied to Sirius deal costs, while Casgevy adoption gains momentum across global markets.

VRTX Q2 Earnings Beat, Stock Down as Pain Drug Misses Study Goal

Vertex beats second-quarter earnings and revenue estimates, but shares slide as pain drug VX-993 misses study goal.

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Vertex Pharmaceuticals, Inc.

Buying

Holding

Selling or trimming

Watching from the sidelines

What are you doing with $OPEN stock after the major announcements last night?

Stocktwits

 stock after the major announcements last night?

VRTX
Vertex Pharmaceuticals, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest VRTX News

VRTX Vertex Pharmaceuticals, Inc.